Skip to main content

Peer Review reports

From: Biweekly cetuximab in combination with FOLFOX-4 in the first-line treatment of wild-type KRAS metastatic colorectal cancer: final results of a phase II, open-label, clinical trial (OPTIMIX-ACROSS Study)

Original Submission
13 May 2014 Submitted Original manuscript
14 May 2014 Author responded Author comments - Luis Cirera
Resubmission - Version 2
14 May 2014 Submitted Manuscript version 2
6 Oct 2014 Author responded Author comments - Luis Cirera
9 Sep 2014 Reviewed Reviewer Report - Kohei Shitara
7 Sep 2014 Reviewed Reviewer Report - Jaw-Yuan Wang
Resubmission - Version 3
6 Oct 2014 Submitted Manuscript version 3
3 Nov 2014 Author responded Author comments - Luis Cirera
19 Oct 2014 Reviewed Reviewer Report - Kohei Shitara
10 Oct 2014 Reviewed Reviewer Report - Jaw-Yuan Wang
Resubmission - Version 4
3 Nov 2014 Submitted Manuscript version 4
Publishing
11 Nov 2014 Editorially accepted
22 Nov 2014 Article published 10.1186/1471-2407-14-865

You can find further information about peer review here.

Back to article page
\